Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Clinical trial NCT06959095 · RECRUITING

Trial details

NCT number: NCT06959095
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2025-06-20
Primary completion: 2029-08-20
Enrollment: 981

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.